1-4 of 4
Robert V.B. Emmons
Close
Sort by
Journal Articles

Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+ T-Cell Malignancies (TCM)

Rita Assi, Nabil Hagag, Sherif Farag, Robert V.B. Emmons, Allie Carter, Magdalena Czader, Rafat Abonour, Lionel Apetoh, Yupo Ma, Huda S. Salman
Journal: Blood
Blood (2023) 142 (Supplement 1): 6854.
https://doi.org/10.1182/blood-2023-180111
Published: 2023
Journal Articles

Role of Nutrition Support in Improving Outcomes in Allogeneic Stem Cell Transplant Patients

Anas Al Bawaliz, Jasdeep Singh Sidhu, Abigail Cecil, Bakeerathan Gunaratnam, Robert V.B. Emmons, Ju-Hsien Chao, Hassaan Yasin, Mohamed Hegazi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6971.
https://doi.org/10.1182/blood-2023-189960
Published: 2023
Journal Articles

Efficacy and Safety of Tixagevimab-Cilgavimab (Evusheld or AZD7442) As Pre-Exposure Prophylaxis for COVID-19 Among Allogeneic Hematopoietic Stem Cell Transplant Recipients

Quan Do, Waled Bahaj, Natasha Chandler, Ju-Hsien Chao, Robert V.B. Emmons, Mohamed Hegazi
Journal: Blood
Blood (2023) 142 (Supplement 1): 7109.
https://doi.org/10.1182/blood-2023-173224
Published: 2023
Journal Articles

Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft Versus Host Disease Prophylaxis in Patients Undergoing Allogenic Stem Cell Transplant: A Single Institution Experience

Hamza Hashmi, MD, Shruti Bhandari, MD, Xiaoyong Wu, Shesh Nath Rai, William Tse, MD, Robert V.B. Emmons, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5728.
https://doi.org/10.1182/blood-2018-99-115422
Published: 2018